Protocol Ledger

NCT06692556 · Phase III · RECRUITING

Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence

Interventional Phase III clinical trial protocol NCT06692556 sponsored by Centre Leon Berard in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-02-21 Enrollment: 266 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06692556
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)266 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06692556
Protocol FieldVerified Registry Value
NCT IdentifierNCT06692556
Consolidated Lead SponsorCentre Leon Berard
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment266 participants (ESTIMATED)
Registered Start Date2025-02-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06692556
Hospital Research SiteLocationSite Profile
Centre Georges-François LeclercDijon, FranceOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI